首页 › 基金 › ADVOCATE GROUP LLC › ABBV

ADVOCATE GROUP LLC 对 ABBV 的持仓历史

ABBVIE INC · 医疗保健

ADVOCATE GROUP LLC 在 Q3 2026 的 13F 申报中披露持有 ABBV(ABBVIE INC)67,923 股,市值约 US$17.8M,约占其申报组合的 2.75%,在其申报持仓中市值排名第 3 位。 ADVOCATE GROUP LLC 最近 13 个申报季度中有 13 个季度披露了 ABBV 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)67.92K 股
申报持仓市值$17.77M
组合权重2.75%
首次申报Q3 2023
最近变动减持
更新于2026-10-21

最后更新: 2026-10-21 · 来源: SEC EDGAR Form 13F-HR

ADVOCATE GROUP LLC 对 ABBV 的持仓演变

ADVOCATE GROUP LLC 于 Q3 2023 首次披露 ABBV 持仓:79,223 股(约 US$11.8M)。 该持仓在 Q3 2025 达到峰值 82,247 股,市值约 US$19.0M。 在 13 次申报中,ADVOCATE GROUP LLC 4 次增持、7 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 67,923 股、市值约 US$17.8M,环比减持 -7,144 股。。

逐季持仓明细

季度股数金额变化
Q3 2023 79.22K $11.81M 新进
Q4 2023 78.21K $12.12M 减持
Q1 2024 77.40K $14.09M 减持
Q2 2024 77.00K $13.21M 减持
Q3 2024 77.29K $15.26M 持有
Q4 2024 77.95K $13.85M 增持
Q1 2025 79.14K $16.58M 增持
Q2 2025 81.30K $15.09M 增持
Q3 2025 82.25K $19.04M 增持
Q4 2025 76.21K $17.41M 减持
Q1 2026 75.67K $16.46M 减持
Q2 2026 75.07K $18.89M 减持
Q3 2026 67.92K $17.77M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ABBV 与 13F 数据

ABBV(ABBVIE INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 ABBV,申报仓位最大的包括:先锋集团 (US$41.31B), 贝莱德 (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABBV 的基金

查看 ABBV 的全部基金持有人 →

常见问题

How long has ADVOCATE GROUP LLC held ABBV?

ADVOCATE GROUP LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ADVOCATE GROUP LLC's current position in ABBV?

As of Q3 2026, ADVOCATE GROUP LLC holds 67.92K shares of ABBV (ABBVIE INC), valued at $17.77M, representing 2.75% of its reported portfolio and ranking #3.

Has ADVOCATE GROUP LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), ADVOCATE GROUP LLC reduced its position in ABBV. The position peaked in Q3 2025 at 82.25K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include 先锋集团, 贝莱德, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.